Literature DB >> 26092827

Drug-induced glomerular disease: immune-mediated injury.

Jonathan J Hogan1, Glen S Markowitz2, Jai Radhakrishnan3.   

Abstract

Drug-induced autoimmune disease was initially described decades ago, with reports of vasculitis and a lupus-like syndrome in patients taking hydralazine, procainamide, and sulfadiazine. Over the years, multiple other agents have been linked to immune-mediated glomerular disease, often with associated autoantibody formation. Certain clinical and laboratory features may distinguish these entities from their idiopathic counterparts, and making this distinction is important in the diagnosis and management of these patients. Here, drug-induced, ANCA-associated vasculitis, drug-induced lupus, and drug-associated membranous nephropathy are reviewed.
Copyright © 2015 by the American Society of Nephrology.

Entities:  

Keywords:  ANCA; GN; SLE; drug nephrotoxicity; membranous nephropathy

Mesh:

Substances:

Year:  2015        PMID: 26092827      PMCID: PMC4491282          DOI: 10.2215/CJN.01910215

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  120 in total

Review 1.  Minocycline-induced lupus. A systematic review.

Authors:  R G Schlienger; A J Bircher; C R Meier
Journal:  Dermatology       Date:  2000       Impact factor: 5.366

2.  Cephotaxime-associated allergic interstitial nephritis and MPO-ANCA positive vasculitis.

Authors:  S Feriozzi; A O Muda; V Gomes; M Montanaro; T Faraggiana; E Ancarani
Journal:  Ren Fail       Date:  2000-03       Impact factor: 2.606

Review 3.  Role of apoptosis in autoimmunity.

Authors:  H M Lorenz; M Herrmann; T Winkler; U Gaipl; J R Kalden
Journal:  Apoptosis       Date:  2000-11       Impact factor: 4.677

4.  Complement system protein C4 and susceptibility to hydralazine-induced systemic lupus erythematosus.

Authors:  C Speirs; A H Fielder; H Chapel; N J Davey; J R Batchelor
Journal:  Lancet       Date:  1989-04-29       Impact factor: 79.321

5.  The formation of autoantibodies and antibodies to TNF-α blocking agents in relation to clinical response in patients with ankylosing spondylitis.

Authors:  S Arends; H R Lebbink; A Spoorenberg; L B Bungener; C Roozendaal; E van der Veer; P M Houtman; E N Griep; P C Limburg; C G M Kallenberg; G J Wolbink; E Brouwer
Journal:  Clin Exp Rheumatol       Date:  2010-10-22       Impact factor: 4.473

6.  Hydralazine-induced ANCA-positive pauci-immune glomerulonephritis: a case report and literature review.

Authors:  Mirela Dobre; Jay Wish; Lavinia Negrea
Journal:  Ren Fail       Date:  2009       Impact factor: 2.606

7.  Clinical course of bucillamine-induced nephropathy in patients with rheumatoid arthritis.

Authors:  Mie Obayashi; Takashi Uzu; Tamaki Harada; Masafumi Yamato; Ken Takahara; Atsushi Yamauchi
Journal:  Clin Exp Nephrol       Date:  2003-12       Impact factor: 2.801

8.  Propylthiouracil-induced rapidly progressive glomerulonephritis associated with antineutrophil cytoplasmic autoantibodies.

Authors:  Y Kudoh; S Kuroda; K Shimamoto; O Iimura
Journal:  Clin Nephrol       Date:  1997-07       Impact factor: 0.975

9.  Autoantibodies to leucocyte antigens in hydralazine-associated nephritis.

Authors:  G Almroth; S Eneström; J Hed; I Samuelsson; P Sjöström
Journal:  J Intern Med       Date:  1992-01       Impact factor: 8.989

Review 10.  Trojan horses: drug culprits associated with antineutrophil cytoplasmic autoantibody (ANCA) vasculitis.

Authors:  William F Pendergraft; John L Niles
Journal:  Curr Opin Rheumatol       Date:  2014-01       Impact factor: 5.006

View more
  28 in total

1.  Pauci-immune crescentic glomerulonephritis associated with use of trimethoprim-sulfamethoxazole.

Authors:  Shruti S Hegde; Vanesa Bijol; Bertrand L Jaber
Journal:  CEN Case Rep       Date:  2016-06-07

2.  Rituximab for the management of idiopathic membranous nephropathy: a meta-analysis.

Authors:  Lan Huang; Qiao-Rong Dong; Ya-Juan Zhao; Gui-Cai Hu
Journal:  Int Urol Nephrol       Date:  2020-09-17       Impact factor: 2.370

Review 3.  Anti-neutrophil cytoplasmic antibodies and their clinical significance.

Authors:  Supaporn Suwanchote; Muanpetch Rachayon; Pongsawat Rodsaward; Jongkonnee Wongpiyabovorn; Tawatchai Deekajorndech; Helen L Wright; Steven W Edwards; Michael W Beresford; Pawinee Rerknimitr; Direkrit Chiewchengchol
Journal:  Clin Rheumatol       Date:  2018-03-10       Impact factor: 2.980

4.  Mercury in natural health products as a cause of membranous nephropathy.

Authors:  Stephen Tanner; Vivek Sharma; Deborah Jebakumar; Mohanram Narayanan; Arundhati Rao
Journal:  Proc (Bayl Univ Med Cent)       Date:  2020-01-30

Review 5.  Primary Membranous Nephropathy.

Authors:  William G Couser
Journal:  Clin J Am Soc Nephrol       Date:  2017-05-26       Impact factor: 8.237

6.  A case of denosumab-associated membranous nephropathy in a patient with rheumatoid arthritis.

Authors:  Miyuki Kimoto; Naoya Fukunaga; Nahomi Yamaguchi; Misaki Maruo; Kohei Aoki; Akihiro Fukuda; Takeshi Nakata; Satoshi Hisano; Hirotaka Shibata
Journal:  CEN Case Rep       Date:  2019-09-23

Review 7.  The Changing Landscape of Renal Inflammation.

Authors:  Thomas Ernandez; Tanya Norton Mayadas
Journal:  Trends Mol Med       Date:  2016-01-07       Impact factor: 11.951

Review 8.  [(Immuno‑)Pathology of drug side effects in the kidney].

Authors:  F Pfister; M Büttner-Herold; K Amann
Journal:  Pathologe       Date:  2018-11       Impact factor: 1.011

9.  Outcomes of hydralazine induced renal vasculitis.

Authors:  Homa Timlin; Jason E Liebowitz; Khusleen Jaggi; Duvuru Geetha
Journal:  Eur J Rheumatol       Date:  2017-12-07

10.  Novel organophosphorus aminopyrimidines as unique structural DNA-targeting membrane active inhibitors towards drug-resistant methicillin-resistant Staphylococcus aureus.

Authors:  Di Li; Rammohan R Yadav Bheemanaboina; Narsaiah Battini; Vijai Kumar Reddy Tangadanchu; Xian-Fu Fang; Cheng-He Zhou
Journal:  Medchemcomm       Date:  2018-08-01       Impact factor: 3.597

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.